ABILIFY ASIMTUFII
ABILIFY ASIMTUFII
Approved
DIN Number
02554577
Drug Class
Human
Market Date
Mar 20, 2025
Company
HC
OTSUKA PHARMACEUTICAL CO., LTD.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02554577
AIG Number0152514007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX12 ARIPIPRAZOLE
Product Specifications
Dosage FormSuspension (Extended-Release)
Route of AdministrationIntramuscular
AHFS Classification28:16.08.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
ARIPIPRAZOLEActive
Strength: 960 MG / 3.2 ML
Monograph: ARIPIPRAZOLE